这项目前仍在进行中的研究开始于1999年，为调查普通筛查人群的危险因素；
The ongoing study began in 1999 to investigate risk factors in a general screening population;
LUX试验项目是一项综合且富有活力的项目，其包括超过10项全球进行中的试验，这些试验在多种实体肿瘤研究Afatinib的效果。
The LUX trial program is a comprehensive and robust program that comprises more than 10 trials conducted across the globe, investigating afatinib in a variety of different solid tumor types.
应用推荐